Cargando…
Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer
The clinical relevance of bax and bcl-2 protein expression has been investigated in 84 patients with recurrent or metastatic colorectal cancer submitted to a chemotherapy regimen including methotrexate and fluorouracil/leucovorin. Cytoplasmic immunostaining of bax and bcl-2 was present in 65.5% and...
Autores principales: | Paradiso, A, Simone, G, Lena, M De, Leone, B, Vallejo, C, Lacava, J, Dellapasqua, S, Daidone, M G, Costa, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363782/ https://www.ncbi.nlm.nih.gov/pubmed/11237386 http://dx.doi.org/10.1054/bjoc.2000.1658 |
Ejemplares similares
-
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
por: Paradiso, A, et al.
Publicado: (2000) -
Biomarkers and outcome after tamoxifen treatment in node-positive breast cancers from elderly women
por: Daidone, M G, et al.
Publicado: (2000) -
5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer
por: Jodrell, D I, et al.
Publicado: (2001) -
The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000) -
Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma
por: Assersohn, L, et al.
Publicado: (1999)